Given our strategic location in the heart of Maryland’s vibrant biotech landscape, and our unique access to specialty items such as Remicade (Infliximab) and other antibody’s and injectables, Blue Door Pharma has become the “go to” distributor for many procurement officers.
Blue Door Pharma’s current customers are primarily US-based biotech companies with a general focus on pharmaceutical and biopharmaceutical research and development, and include some of the leaders in the industry, all who appreciate the value, quality, and service we provide.
Remicade is a monoclonal antibody against tumor necrosis factor alpha used to treat autoimmune diseases. Infliximab has been approved by the (FDA) for the treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis,rheumatoid arthritis, and ulcerative colitis.
Remicade comes packaged as 100 mg of lyophilized infliximab in a 20 mL vial for intravenous infusion.